Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

Epigenetic mechanisms in oral carcinogenesis.

Gasche JA, Goel A.

Future Oncol. 2012 Nov;8(11):1407-25. doi: 10.2217/fon.12.138. Review.

2.

MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.

Wiklund ED, Gao S, Hulf T, Sibbritt T, Nair S, Costea DE, Villadsen SB, Bakholdt V, Bramsen JB, Sørensen JA, Krogdahl A, Clark SJ, Kjems J.

PLoS One. 2011;6(11):e27840. doi: 10.1371/journal.pone.0027840. Epub 2011 Nov 22.

3.

Epigenetic disregulation in oral cancer.

Mascolo M, Siano M, Ilardi G, Russo D, Merolla F, De Rosa G, Staibano S.

Int J Mol Sci. 2012;13(2):2331-53. doi: 10.3390/ijms13022331. Epub 2012 Feb 21. Review.

4.

Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.

Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J.

Cancer Res. 2008 Apr 1;68(7):2094-105. doi: 10.1158/0008-5472.CAN-07-5194.

5.

Epigenetics in prostate cancer: biologic and clinical relevance.

Jerónimo C, Bastian PJ, Bjartell A, Carbone GM, Catto JW, Clark SJ, Henrique R, Nelson WG, Shariat SF.

Eur Urol. 2011 Oct;60(4):753-66. doi: 10.1016/j.eururo.2011.06.035. Epub 2011 Jun 22. Review.

PMID:
21719191
6.

Epigenetic alterations of the keratin 13 gene in oral squamous cell carcinoma.

Naganuma K, Hatta M, Ikebe T, Yamazaki J.

BMC Cancer. 2014 Dec 20;14:988. doi: 10.1186/1471-2407-14-988.

7.

Genetic and Epigenetic Biomarkers of Molecular Alterations in Oral Carcinogenesis.

Dumache R, Rogobete AF, Andreescu N, Puiu M.

Clin Lab. 2015;61(10):1373-81. Review.

PMID:
26642697
8.

Histones and long non-coding RNAs: the new insights of epigenetic deregulation involved in oral cancer.

González-Ramírez I, Soto-Reyes E, Sánchez-Pérez Y, Herrera LA, García-Cuellar C.

Oral Oncol. 2014 Aug;50(8):691-5. doi: 10.1016/j.oraloncology.2014.04.006. Epub 2014 May 17. Review.

PMID:
24844984
9.

Comprehensive epigenetic analysis using oral rinse samples: a pilot study.

Kusumoto T, Hamada T, Yamada N, Nagata S, Kanmura Y, Houjou I, Kamikawa Y, Yonezawa S, Sugihara K.

J Oral Maxillofac Surg. 2012 Jun;70(6):1486-94. doi: 10.1016/j.joms.2011.04.021. Epub 2011 Aug 6.

PMID:
21821326
10.

Epigenome and DNA methylation in oral squamous cell carcinoma.

García MP, García-García A.

Methods Mol Biol. 2012;863:207-19. doi: 10.1007/978-1-61779-612-8_12. Review.

PMID:
22359295
11.

Epigenetic inactivation of DNA repair in breast cancer.

Nowsheen S, Aziz K, Tran PT, Gorgoulis VG, Yang ES, Georgakilas AG.

Cancer Lett. 2014 Jan 28;342(2):213-22. doi: 10.1016/j.canlet.2012.05.015. Epub 2012 May 23. Review.

PMID:
22634493
12.

Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.

Nayak S, Goel MM, Makker A, Bhatia V, Chandra S, Kumar S, Agarwal SP.

PLoS One. 2015 Oct 14;10(10):e0138801. doi: 10.1371/journal.pone.0138801. eCollection 2015.

13.

Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis.

Zhou S, Chen L, Mashrah M, Zhu Y, He Z, Hu Y, Xiang T, Yao Z, Guo F, Zhang C.

Oncol Rep. 2015 Nov;34(5):2636-42. doi: 10.3892/or.2015.4264. Epub 2015 Sep 9.

PMID:
26352791
14.

Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.

Sigalotti L, Fratta E, Coral S, Cortini E, Covre A, Nicolay HJ, Anzalone L, Pezzani L, Di Giacomo AM, Fonsatti E, Colizzi F, Altomonte M, Calabrò L, Maio M.

J Cell Physiol. 2007 Aug;212(2):330-44. Review.

PMID:
17458893
15.

Downregulated miR329 and miR410 promote the proliferation and invasion of oral squamous cell carcinoma by targeting Wnt-7b.

Shiah SG, Hsiao JR, Chang WM, Chen YW, Jin YT, Wong TY, Huang JS, Tsai ST, Hsu YM, Chou ST, Yen YC, Jiang SS, Shieh YS, Chang IS, Hsiao M, Chang JY.

Cancer Res. 2014 Dec 15;74(24):7560-72. doi: 10.1158/0008-5472.CAN-14-0978. Epub 2014 Oct 28.

16.

Promoter hypermethylation and silencing of tissue factor pathway inhibitor-2 in oral squamous cell carcinoma.

Lai YH, He RY, Chou JL, Chan MW, Li YF, Tai CK.

J Transl Med. 2014 Sep 2;12:237. doi: 10.1186/s12967-014-0237-7.

17.

Epigenetic regulators governing cancer stem cells and epithelial-mesenchymal transition in oral squamous cell carcinoma.

Patel S, Shah K, Mirza S, Daga A, Rawal R.

Curr Stem Cell Res Ther. 2015;10(2):140-52. Review.

PMID:
25330402
18.

Feedback networks between microRNAs and epigenetic modifications in urological tumors.

Liep J, Rabien A, Jung K.

Epigenetics. 2012 Apr;7(4):315-25. doi: 10.4161/epi.19464. Epub 2012 Apr 1. Review.

PMID:
22414795
19.

Genetic or epigenetic silencing of low density lipoprotein receptor-related protein 1B expression in oral squamous cell carcinoma.

Nakagawa T, Pimkhaokham A, Suzuki E, Omura K, Inazawa J, Imoto I.

Cancer Sci. 2006 Oct;97(10):1070-4.

20.

miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes.

Hung PS, Liu CJ, Chou CS, Kao SY, Yang CC, Chang KW, Chiu TH, Lin SC.

PLoS One. 2013 Nov 26;8(11):e79926. doi: 10.1371/journal.pone.0079926. eCollection 2013.

Supplemental Content

Support Center